187 related articles for article (PubMed ID: 24736256)
1. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
Carrizo A; Campbell S
Medicina (B Aires); 2014; 74(2):121-3. PubMed ID: 24736256
[TBL] [Abstract][Full Text] [Related]
2. On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.
Skeppholm M; Hjemdahl P; Antovic JP; Muhrbeck J; Eintrei J; Rönquist-Nii Y; Pohanka A; Beck O; Malmström RE
Thromb Res; 2014 Oct; 134(4):783-9. PubMed ID: 25172669
[TBL] [Abstract][Full Text] [Related]
3. Reversal of dabigatran with haemodialysis in a patient requiring decompression for cord compression from an epidural abscess.
Lowe MP; Collins J; Yehia M; Eaddy N
Nephrology (Carlton); 2013 Aug; 18(8):580-2. PubMed ID: 23865545
[No Abstract] [Full Text] [Related]
4. Removal of dabigatran by hemodialysis.
Chang DN; Dager WE; Chin AI
Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
[TBL] [Abstract][Full Text] [Related]
5. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O
Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
Singh T; Maw TT; Henry BL; Pastor-Soler NM; Unruh ML; Hallows KR; Nolin TD
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1533-9. PubMed ID: 23704302
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
8. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
Tkacheva ON; Akasheva DU
Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients.
Czubek U; Góralczyk T; Zalewski J; Undas A
Pol Arch Med Wewn; 2014; 124(9):487-9. PubMed ID: 25203142
[No Abstract] [Full Text] [Related]
10. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
Chen BC; Sheth NR; Dadzie KA; Smith SW; Nelson LS; Hoffman RS; Winchester JF
Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
[TBL] [Abstract][Full Text] [Related]
13. Safe use of hemodialysis for dabigatran removal before cardiac surgery.
Wanek MR; Horn ET; Elapavaluru S; Baroody SC; Sokos G
Ann Pharmacother; 2012 Sep; 46(9):e21. PubMed ID: 22872748
[TBL] [Abstract][Full Text] [Related]
14. Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays.
van Ryn J; Grottke O; Spronk H
Clin Lab Med; 2014 Sep; 34(3):479-501. PubMed ID: 25168938
[TBL] [Abstract][Full Text] [Related]
15. The use of dabigatran immediately after atrial fibrillation ablation.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
17. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
18. [Expectation to and problems of thrombin inhibitor].
Uchiyama S
Rinsho Shinkeigaku; 2011 Nov; 51(11):1004-6. PubMed ID: 22277458
[TBL] [Abstract][Full Text] [Related]
19. Assessment of dabigatran utilization and prescribing patterns for atrial fibrillation in a physician group practice setting.
Carley B; Griesbach S; Larson T; Krueger K
Am J Cardiol; 2014 Feb; 113(4):650-4. PubMed ID: 24484861
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Lillo-Le Louët A; Wolf M; Soufir L; Galbois A; Dumenil AS; Offenstadt G; Samama MM
Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
